Drug-induced aplastic anaemia: clinical aspects.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000375:Aging; D000741:Anemia, Aplastic / Q000139:chemically induced* / Q000209:etiology / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000009:adverse effects; D003078:Colchicine / Q000009:adverse effects; D004008:Diclofenac / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008472:Medazepam / Q000009:adverse effects; D008875:Middle Aged; D010113:Oxyphenbutazone / Q000009:adverse effects; D010396:Penicillamine / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D011379:Prognosis; D011796:Quinacrine / Q000009:adverse effects
D004008:Diclofenac; D002701:Chloramphenicol; D010653:Phenylbutazone; D010396:Penicillamine; D011796:Quinacrine; D010113:Oxyphenbutazone; D008472:Medazepam; D003078:Colchicine